Citations

Institution: Mayo Clinic Clear

Showing 10 of 108119 citations.

Fungi in the Airways: Associations With Bacterial and Mycobacterial Co-isolation in Patients With Bronchiectasis
Alitelat, Alwatheq , Aksamit, T.R., Chalmers, Sarah , Escalante, Patricio , Peikert, Tobias, Limper, A.H., Kanj, A.N., Patel, Robin , Skalski, Joseph H.

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A4552-A4552

10.1164/ajrccm.2025.211.abstracts.a4552 Get It

Abstract RATIONALE: Understanding co-isolation patterns between fungi and other potentially pathogenic microorganisms in the airways of bronchiectasis patients is important for uncovering possible microbial interactions and informing treatment. Although numerous organisms have been identified in respiratory cultures, the specific patterns of their co-isolation are underexplored. OBJECTIVES: To examine the patterns of co-isolation between fungi and bacteria or mycobacteria in respiratory samples from patients with bronchiectasis across a large national health system. METHODS: We reviewed 58,170 respiratory culture tests from 8,194 patients with bronchiectasis (identified using ICD-10-CM codes J47.0, J47.1, and J47.9) across Mayo Clinic. These tests were analyzed for fungal, bacterial, and mycobacterial growth, focusing on co-isolation from the same sample. Chi-square statistics were used to compute p-values. RESULTS: Of all 18,983 samples cultured for fungi, 59% were positive. Of these, 72% yielded yeasts and 40% molds. Among the 11,372 samples cultured for both fungi and bacteria, 681 (6%) showed co-isolation, representing 54% of positive bacterial cultures. The odds of bacterial co-isolation with fungi were 1.4 (95% CI: 1.3-1.6; p < 0.01), driven by yeasts (OR: 1.5, 95% CI: 1.3-1.7; p < 0.01), rather than molds (OR: 1.0, 95% CI: 0.9-1.2; p = 0.8). Pseudomonas species, the most common bacterial isolate, had a higher likelihood of co-isolation with fungi (OR: 1.6, 95% CI: 1.3-1.9; p < 0.01), particularly yeasts (OR: 1.6, 95% CI: 1.4-2.0; p < 0.01). Molds, including those from genera such as aspergillus and penicillium, did not show a significant association with the isolation of pseudomonas. On the other hand, among the 15,859 samples cultured for both fungi and mycobacteria, 1352 (9%) showed co-isolation, representing 62% of positive mycobacterial cultures. Odds of co-isolation were 1.7 (95% CI: 1.5-1.8; p < 0.01). Molds showed a stronger association with isolation of mycobacteria (OR: 1.7, 95% CI: 1.5-1.9; p < 0.01) compared to bacteria, while yeasts also had elevated odds (OR: 1.4, 95% CI: 1.2-1.5). CONCLUSIONS: Distinct patterns of fungal co-isolation with bacteria and mycobacteria have been observed in bronchiectasis, which may influence key aspects of the disease, such as inflammation and mucociliary dysfunction. Advanced metagenomic and immunoprofiling techniques could provide deeper insights into these co-isolation patterns while considering other factors like clinical demographics, previous antibiotic exposure, and disease severity. Understanding whether altering the mycobiome could modify these aspects and improve outcomes remains an important avenue for research.
Pulmonary Arterial Pulsatility Index in Portopulmonary Hypertension
Assis, Monique Ribeiro de , Frias, J. Sinclair de, Torp, Kari, Ghosh, Souvik , Assis, M., Frias, J. Sinclair de, Franco, Pablo Moreno , Torp, K.

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A4330-A4330

10.1164/ajrccm.2025.211.abstracts.a4330 Get It

Abstract Rationale Pulmonary artery pulsatility index (PAPi) is defined as pulmonary artery pulse pressure divided by right atrial pressure and has been identified as a predictor of mortality in pulmonary hypertension. Portopulmonary-hypertension (POPH), a subset associated with portal hypertension, lacks a clear prognostic association with PAPi. This study aimed to assess whether perioperative PAPi values correlate with outcomes in liver transplant patients with POPH. Methods This single-center, retrospective study included POPH patients undergoing liver transplantation at Mayo Clinic Florida from June 2003 to December 2023. 69 patients were categorized based on the lower PAPi quartile in our dataset (>0.9 or ≤ 0.9), measured via catheterization within one day of transplantation, comparing baseline characteristics and outcomes. Categorical variables were analyzed using chi-square or Fisher's exact tests, while continuous variables were compared with independent t-tests or Mann-Whitney U tests. Unadjusted and adjusted odds ratios (ORs) for 1-year mortality were calculated using logistic regression for baseline comorbidities and univariate significance. Results Most patients were white (91.3%) and non-Hispanic (82.6%), with a mean BMI of 29.3 kg/m² and MELD score of 20.3. Mean hemodynamic data included heart rate of 75.8 bpm, pulmonary artery pressure of 29.9 mmHg, right atrial pressure of 15.1 mmHg, and PAPi of 1.25. Mortality rates were 7.2% at 30 days, 10.1% at 90 days, and 11.6% at 1 year. Patients with PAPi >0.9 (n=50) were older (mean age 58.2 vs. 52.9) than those with PAPi ≤0.9 (n=19). The PAPi >0.9 group was predominantly white (94% vs. 84.2%, p=0.04), with no significant differences in BMI, MELD scores, or ethnicity. Mortality at 30 and 90 days was higher in the PAPi >0.9 group (10% and 14%, respectively) compared to the PAPi ≤0.9 group (0% for both); however, differences were not statistically significant. At 1 year, mortality was 14% in the PAPi >0.9 group and 5.3% in the PAPi ≤0.9 group, with no statistical significance. Multivariate analysis indicated no association between PAPi and 1-year mortality (OR 0.12-0.24, p=0.2-0.3), and PAPi as a continuous variable showed no link with 1-year mortality. Conclusions PAPi was not significantly associated with 1-year mortality in liver transplant patients with POPH, suggesting that it should not be used alone to decide listing for transplantation. Further studies with larger cohorts are needed to confirm these findings or identify alternative hemodynamic markers or PAPi values predictive of long-term outcomes in this high-risk group.
Quantification of Lung Water by Thoracic CT in Heart Failure Patients
Vungarala, Soumya , Wentz, Robert J., Olson, Lyle J. , Johnson, Bruce D.

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A4313-A4313

10.1164/ajrccm.2025.211.abstracts.a4313 Get It

Abstract Rationale: Heart failure (HF) is often characterized by elevated left ventricular filling pressures (LVFP) and pulmonary congestion. However, LVFP may not always predict congestion. Pulmonary congestion can be quantified by computed tomography (CT) imaging. We hypothesized that extravascular lung water quantified by CT may differ in HF groups such as HF with preserved ejection fraction (HFpEF) vs HF with reduced ejection fraction (HFrEF), inpatients with acute decompensated heart failure (ADHF) vs stable and this would be related to echocardiography (echo) derived estimates of LVFP. Methods: We enrolled and studied 83 patients with HF who were either admitted or had a clinic visit at Mayo Clinic, Rochester, MN from May 2018 through March 2019. All subjects underwent comprehensive echo and supine thoracic CT scans. CT lung fluid was quantified and reported as proportion (%) of total lung volume. CT attenuation in lung tissue was also measured. LVFP was evaluated according to standardized echo diagnostic algorithms. Patients were stratified based on clinical diagnosis of HF as inpatients with HFpEF (n=26, 75.6±8.5yrs, M=50%, BMI=36.2±8.9kg/m2) inpatients with HFrEF (n=33, 75.6±14yrs, M=79%, BMI=31.1±9.1kg/m2), inpatients with ADHF (n=14, 72.6±14.5yrs, m=64.2%, BMI= 32.2±7.6Kg/m2) and stable outpatient HF controls (n=10, 65±13 yrs, m=90%, BMI= 29.5±5.2Kg/m2). All four groups were compared using one-way ANOVA followed by a post-hoc analysis. A correlation between lung fluid % and LVFP was performed using Spearman's correlation test. Results: When HF groups were compared according to CT % lung fluid, significant differences were found between HF groups (p=0.004). Post-hoc analysis revealed a significant difference in % lung fluid as HFrEF group had higher mean value in % lung fluid compared to HF control group (p=0.004). Similarly, ADHF group had higher mean % lung fluid compared to HF control group (p= 0.007). However, we found no correlation between LVFP and % lung fluid. The rightward shift in CT attenuation for HFpEF, HFrEF, and ADHF subjects, as displayed in figure 1, suggests greater levels of % lung water in these subjects compared to controls. Conclusion: These data suggest that CT measures of lung water differ in subgroups of HF patients and may not correlate with LVFP.
Menopause is Not Associated With Asthma or Severe Asthma
Li, S. , Kim, H.J., Zein, Joe , Silveyra, Patricia , Attaway, Amy

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A4226-A4226

10.1164/ajrccm.2025.211.abstracts.a4226 Get It

Abstract RATIONALE: Significant sex differences exist in the prevalence and severity of asthma across the lifespan. Asthma is more prevalent and severe in pubescent boys compared to girls but worse in girls and women after puberty. The transition to menopause brings significant reductions in estrogen and progesterone levels. In this study, we test the hypothesis that the effect of menopause on asthma prevalence and outcomes is modified by the use of female sex hormones. METHODS: We used data from nine two-year cycles (1999-2000 to 2015-2016) from NHANES to determine the association between menopause and asthma outcomes. We defined severe asthma based on GINA treatment classes 4&5. We used analytic sample weights to compute national estimates according to NHANES guidelines. Adult (age >18 years) women were considered to be menopaused if (1) they reported to be menopaused during the NHANES survey, (2) they had bilateral oophorectomy, or (3) they were ≥52 years. Weighted logistic regression analyses were used to adjust for age, race, body mass index (BMI), smoking, blood eosinophil count, female hormone therapy, and oral contraceptives. Analyses were performed using the SURVEY package in R. RESULTS: The cohorts’ clinical characteristics are listed in table 1. Compared to pre-menopause (weighted n=60,394,897), menopause (weighted n=52,364,594) was associated with higher rates of active asthma (9.2 vs. 8.9%, p=0.004) and severe asthma (5% vs. 1.8%, p<0.001), but not lifetime asthma (15.1 vs. 16.3%, p=0.063). Notably, postmenopausal women had higher BMIs (weighted median [IQR]: 28.1 [24.2-33.1] vs. 26.1 [22.6-32.1], p<0.001), longer asthma durations (weighted median [IQR]: 20.0 [7.0-41.0] vs. 15.0 [8.0-24.0], p<0.001), and lower lung functions (p<0.001) (table 1). Adjusted analysis did not show significant associations between menopause and lifetime asthma (adjusted OR, 1.074; 95% CI, 0.901-1.280), active asthma (adjusted OR, 1.072; 95% CI, 0.865-1.328), or severe asthma (adjusted OR, 1.369; 95% CI, 0.958-1.954). Interestingly, a history of female hormone therapy and oral contraceptives use was associated with a higher risk of lifetime asthma (adjusted OR, 1.191; 95% CI, 1.031-1.375 and adjusted OR, 1.287; 95% CI, 1.169-1.417 respectively). Among women with active asthma, menopause was not associated with non-severe exacerbations (adjusted OR, 1.335; 95% CI, 0.883-2.021) or with severe exacerbations requiring ER visits (adjusted OR, 1.416; 95% CI, 0.818-2.451). Conclusion: The increased prevalence of active asthma and severe asthma among menopausal women can largely be attributed to age-related changes, comorbidities, and hormone therapy use rather than menopause alone.
Hysterectomy Influences Asthma Risk and Severity in Menopausal Women
Kim, H.J., Joudeh, N., Zein, Joe , Silveyra, Patricia

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A4225-A4225

10.1164/ajrccm.2025.211.abstracts.a4225 Get It

Abstract RATIONALE: Women are more likely to develop asthma after puberty, and their symptoms can fluctuate during the menstrual cycle, pregnancy, and menopause. Menopausal women with asthma face unique challenges, as hormonal fluctuations during this stage can impact respiratory health. About one-third of women undergo hysterectomy before age 60, with most procedures occurring before natural menopause. While half of these surgeries preserve the ovaries, the other half include oophorectomy, creating distinct hormonal environments. Despite the traditional view of the uterus as hormonally inactive, there remains a critical gap in our understanding of the potential impact of hysterectomy on respiratory health.METHODS: We used data from nine two-year cycles (1999-2000 to 2015-2016) from NHANES to determine the association between hysterectomy and asthma phenotypes. Severe asthma was defined based on GINA treatment classes 4&5. Analytic sample weights were used according to published NHANES guidelines to create national estimates. Asthma status (lifetime, active, severe) was obtained for women without (weighted n=90,348,593) or with a history of hysterectomy (weighted n=22,310,898). Weighted logistic regression analyses were used to determine the impact of hysterectomy on asthma prevalence, severity, exacerbations, and asthma-related emergency room (ER) visits adjusting for age, race, body mass index (BMI), smoking history, blood eosinophil count, a history of unilateral or bilateral oophorectomy, female hormone therapy, and oral contraceptive use. Analyses were performed using the SURVEY package in R.RESULTS: Clinical characteristics of women with and without a history of hysterectomy are listed in Table 1. Overall, hysterectomy was associated with higher asthma prevalence (18.1 vs. 15.1%) and severity (5.1 vs. 2.9%). For all women, hysterectomy was associated with a higher risk for lifetime asthma (adjusted OR, 1.262; 95% CI, 1.1079-1.477) but not for active asthma (adjusted OR, 1.146; 95% CI, 0.93-1.412) or severe asthma (adjusted OR, 0.996; 95% CI, 0.748-1.325). Interestingly, oophorectomy was associated with a higher risk for lifetime asthma (adjusted OR, 1.228; 95% CI, 1.102-1.368 for unilateral; adjusted OR, 1.232; 95% CI, 1.232-1.513 for bilateral) and active asthma (adjusted OR, 1.417; 95% CI, 1.232-1.629 for unilateral; adjusted OR, 1.507; 95% CI, 1.143-1.986 for bilateral). Among women with active asthma, hysterectomy was associated with severe exacerbations requiring ER visits (adjusted OR, 1.845; 95% CI, 1.157-2.941) but not with non-severe exacerbations (adjusted OR, 1.176; 95% CI, 0.811-1.705).CONCLUSIONS: This study highlights the influence of hysterectomy on asthma risk and severity and emphasizes the role of female hormones in asthma pathogenesis.
Pleural Effusion After Peritoneal Dialysis
Hu, A.W., Jin, Xin

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A4179-A4179

10.1164/ajrccm.2025.211.abstracts.a4179 Get It

Abstract INTRODUCTION While cardiac comorbidities or factors predisposing infection are common in patients with ESRD, one less common cause for pleural effusion in peritoneal dialysis (PD) patients is pleuroperitoneal communication. We present herein a case of a PD patient with large, right-sided pleural effusion one year after starting PD. CASE REPORT An 82-year-old female with ESRD managed on home continuous cycling peritoneal dialysis (CCPD) for 1 year presented to the Emergency Department (ED) with new-onset dyspnea. She recently completed a course of vancomycin for bacterial peritonitis secondary to PD catheter infection. She also reported that her home CCPD machine was not draining the fill amount in recent weeks. She was afebrile and hemodynamically stable on arrival. CT at the ED showed a large, right-sided pleural effusion. She underwent thoracentesis with pending fluid analysis, and experienced subsequent improvement in her dyspnea. She was then hospitalized and wished to continue PD over pursuing intermittent hemodialysis (iHD) while workup was pending, despite clinical suspicion for pleuroperitoneal fistula (PPF). She started inpatient CCPD, and drains following each dwell showed less than expected volumes with no additional output on manual drains. She reported worsening dyspnea the next morning, and bedside POCUS confirmed reaccumulation of her pleural effusion. Fluid analysis revealed a transudative pleural fluid profile, with pleural glucose of 583mg/dL and serum glucose of 80mg/dL. Given her recent peritonitis, suspicion was greatest for PPF. The patient was transitioned from PD to iHD to allow time for the suspected fistula to heal, and subsequent imaging obtained during her hospitalization did not show reaccumulation of her unilateral pleural effusion. DISCUSSION Pleuroperitoneal communication may occur due to congenital or acquired diaphagmatic defects, or insults such as the case in our patient with recent peritonitis. In fact, diaphragmatic blebs from age related degeneration and chronic increased intraabdominal pressure have been reported to cause hydrothorax in patients undergoing PD. Diagnosis of PD-associated pleural effusions is based on clinical suspicion, with pleural studies showing high pleural fluid to serum glucose gradient, and imaging commonly showing unilateral right-sided pleural effusions. Recent peritoneal dialysis with low drainage further supports PD as the etiology. Most cases of PD-associated pleural effusions occur soon after PD initiation, but cases occurring years after initiation have been reported. Management involves halting PD and thoracentesis for symptomatic relief. Patients may need transitioning to iHD indefinitely, or may resume PD after a pause if the cause of communication is reversible.
Rare Case of Nut Allergy After Lung Transplant
Sahota, Raguwinder , Sahota, R.

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A4155-A4155

10.1164/ajrccm.2025.211.abstracts.a4155 Get It

Abstract Food allergy reactions emerging after organ transplantation, particularly following lung transplantation, are uncommon but pose significant clinical challenges. While most documented cases have involved liver transplants and pediatric patients, instances in lung transplant recipients remain rare. Here, we present a case of acute bronchospasm triggered by hummus ingestion, requiring mechanical ventilation in a post-lung transplant patient. This case underscores the need for heightened awareness of potential allergenic reactions in transplant recipients and emphasizes the importance of prompt recognition and management of such reactions in the critical care setting. A 61 year old female experienced an acute respiratory event requiring emergent intubation shortly after ingesting hummus. Initial treatment included duonebs and bronchoscopy, revealing a normal airway architecture but notably stiff lungs. She responded to epinephrine administration. Post-event serum tryptase was within normal limits, suggesting the reaction was primarily respiratory in nature. Despite having a known peanut allergy in her organ donor, her own history was negative for peanut IgE reactivity. Subsequently, she underwent extensive blood IgE testing, confirming negative IgE to peanut, yet yielding positive or equivocal results to chickpea and sesame. Skin testing was positive for “Sabra Snack Hummus,” suggesting reactivity. Prick-to-prick skin testing with chickpea, however, was negative. Additionally, IgE component testing identified Ara h2, a peanut protein with potential cross-reactivity to other legumes, including chickpeas. Managing peanut allergy in post-transplant patients requires careful consideration to prevent severe allergic reactions. Screening is crucial when a donor has a known food allergy, as this can help identify potential allergic responses due to transferred donor immune cells. If a peanut allergy arises post-transplant, strict avoidance of peanuts and cross-reactive allergens, such as certain nuts and legumes, is advised. Transplant recipients with confirmed peanut allergies should carry an epinephrine auto-injector to immediately treat potential anaphylaxis. The pathophysiology of post-transplant food allergies remains under investigation. One theory suggests that donor-derived B lymphocytes producing peanut-specific IgE may enter the recipient's circulation, leading to sensitization. Alternatively, IgE-sensitized mast cells and basophils within the transplanted tissue may react directly in the recipient's lungs or lymph nodes. Another possibility is IgE already attached to mast cells in the bronchial mucosa or lung tissue, heightening allergic reactivity. The safest management includes avoiding all nuts, chickpeas, and sesame seeds, with an epinephrine auto-injector for emergency use. This case underscores the importance of monitoring for food allergies in transplant recipients, especially when the donor has a history of allergies.
A Geriatric Approach to Unexplained Dyspnea: Lurasidone-induced Extrapyramidal Symptoms in a Patient With COPD
Westermeyer, Eliza Thompson

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A4144-A4144

10.1164/ajrccm.2025.211.abstracts.a4144 Get It

Abstract Introduction: Dyspnea is a common and debilitating symptom in chronic obstructive pulmonary disease (COPD) that significantly impacts quality of life. While often attributed to cardiopulmonary causes, other factors such as neuromuscular, psychogenic, or medication-related issues should also be considered. In older adults, polypharmacy, comorbid conditions, and age-related physiological changes can complicate evaluation. A comprehensive geriatric approach, which includes medication review and functional status assessment, is helpful in evaluating persistent dyspnea. Here, we present a case of an older adult with dyspnea thought to be due to extrapyramidal symptoms (EPS) related to antipsychotic use. Case Description: A 75-year-old male with a history of bipolar disorder, diastolic heart failure, 15-pack-year smoking history, and recently diagnosed with COPD presented with persistent dyspnea on exertion. His symptoms began after initiating lurasidone for bipolar disorder. Along with dyspnea, he developed involuntary movements, including sniffing, facial grimacing, cheek sucking, and tremors. Discontinuation of lurasidone resolved the tremors and cheek sucking, but sniffing and grimacing persisted. Pulmonary workup, including high-resolution chest CT and pulmonary function testing, showed mild emphysematous changes, borderline obstruction with significant bronchodilator response, and normal diffusion capacity. A comprehensive cardiac evaluation, including myocardial perfusion stress testing and echocardiogram, revealed no cardiac cause. Despite pulmonary rehabilitation and inhaler therapy, symptoms persisted. Ultimately, he was evaluated by a neurologist and geriatrician. He reported significant decline in engagement in previously enjoyable activities due to his symptoms. During examination, frequent sniffing tics were observed. His dyspnea was thought to be caused by involuntary respiratory muscle movements resulting from extrapyramidal symptoms (EPS) induced by lurasidone, which can persist even after the medication discontinuation. Tetrabenazine, commonly used to manage EPS in antipsychotic-treated patients, was considered but ruled out due to its potential side effects in older adults, including orthostasis, sedation, and depression. Given the patient's previous adverse medication reactions, he was particularly concerned about avoiding further side effects. Therefore, he was prescribed low-dose guanfacine, a medication used to treat tic disorders with a lower risk of side effects. After one month, he reported improvement in his sensation of dyspnea. Discussion: This case highlights the importance of a geriatric approach when evaluating unexplained dyspnea in older adults. Polypharmacy and medication side effects, such as EPS, can mimic or exacerbate respiratory symptoms. The American Geriatrics Society's “5 M's” framework—mind, mobility, medications, multi-complexity, and matters most—helps guide management in this complex patient population.
Never Stop Looking – Making a Genetic Diagnosis of Cystic Fibrosis in an Adult Patient With Bronchiectasis
Reddy, Alyssa , Aksamit, T.R., Chalmers, Sarah , Nanda, S. , Kalscheur, C., Pichurin, Pavel N. , Joshi, Avni Y. , Reddy, A., Iyer, Vivek

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A4131-A4131

10.1164/ajrccm.2025.211.abstracts.a4131 Get It

Abstract Introduction: Cystic fibrosis (CF) is a genetic disorder characterized by defective chloride ion transport, leading to thick mucus production, chronic respiratory infections, and other multisystem involvement. Although CF is often diagnosed in childhood, the condition can be missed or misdiagnosed in adults. Description of Case: We present the case of a 60-year-old male from India who was diagnosed with CF after a prolonged period of sinopulmonary symptoms. He initially presented in 2014. His medical history was pertinent for asthma, and multiple episodes of clinically and radiographically confirmed pneumonia and polypoid sinusitis requiring IV antibiotics and sinus surgery. He carried a prior diagnosis of allergic bronchopulmonary aspergillosis treated with itraconazole and steroids, as well as elevated IgE levels. His CT chest was notable for extensive bronchiectasis, bronchial wall thickening, and mucus plugging of both lungs. He had no known family history of CF. Sweat chloride testing was in the intermediate range (44, 47 mmol/L; normal <30 mmol/L, intermediate 30 to 59 mmol/L, abnormal >59 mmol/L). Given high suspicion for CF, cystic fibrosis transmembrane conductance regulator (CFTR) full gene analysis was pursued. Sequence analysis and multiplex ligation-dependent probe amplification of the CFTR gene detected heterozygous sequence changes c.1717-2A>T, classified as likely deleterious, and c.1367T>C (p.V456A), variant of uncertain significance. He was thus initially diagnosed as a CF carrier. He re-presented in 2024 with decline in pulmonary function testing and continued sinopulmonary infections. Genetic testing results from 2014 were re-analyzed. Between initial presentation and present, his V456A variant was upgraded to pathogenic. He met diagnostic criteria for CF with two pathogenic CFTR variants, a repeated intermediate sweat chloride (47 mmol/L) suggestive of CFTR protein dysfunction, and disease that could be attributed to CFTR dysfunction. He subsequently started TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) and airway clearance therapy. Discussion: The diagnosis of CF in adults can be challenging, particularly in individuals without a known family history, intermediate sweat chloride testing, and with inconclusive genetic testing. Our understanding of CF in Asian populations is limited. CF is suspected to be underreported in patients with Southeast Asian ancestry in part due to genetic heterogeneity. The interpretation of certain genetic variants can evolve over time. A variant of unknown significance may later be reclassified as pathogenic, revealing its true role in disease development. This highlights the critical importance of regularly re-evaluating genetic test results.
Breaking the Mold: A Case of Cystic Fibrosis Beyond Sweat Chloride
Moon, Ju-Young , Chalmers, Sophie , Chalmers, S.

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A4125-A4125

10.1164/ajrccm.2025.211.abstracts.a4125 Get It

Abstract Introduction: Cystic Fibrosis (CF) is traditionally diagnosed through elevated sweat chloride levels followed by genetic testing. However, depending on types of specific CFTR gene mutations, sweat chloride test may not always be conclusive. This case study presents a unique instance of CF in a 50-year-old patient with negative sweat chloride levels who was later found to have CFTR dysfunction during the evaluation for worsening bronchiectasis, highlighting the diagnostic challenges posed by atypical presentations. Description: A 50-year-old female with a long-standing history of bronchiectasis and recurrent exacerbations was evaluated at our clinic. Initial sweat chloride testing yielded negative results (21 and 28 on two separate occasions), which made a CF diagnosis very unlikely. She was subsequently treated with standard airway hygiene measures while alternative diagnoses were explored. However, despite thorough work-up and management, her bronchiectasis continued to worsen, leading to genetic testing to complete the comprehensive evaluation of her condition. The CFTR mutation panel revealed the presence of G551D and D1152H (variants known to be associated with normal sweat chloride test). Despite the negative sweat chloride test, the patient's clinical presentation, including bronchiectasis, recurrent exacerbations, and the identified CFTR mutations, supported a diagnosis of CF. The patient has since responded positively to combination therapy with Elexacaftor, Tezacaftor and Ivacaftor, which is indicated for her genotype. Discussion: This case underscores the limitations of relying solely on sweat chloride testing for diagnosing CF, particularly in patients with atypical CFTR mutations. Variants like D1152H have been reported with normal sweat chloride levels, challenging traditional diagnostic paradigms. Genetic testing plays a crucial role in these cases by identifying mutations that may still lead to significant CFTR dysfunction. The patient's improvement on CFTR modulator therapy further supports the role of genotype-driven treatment strategies in CF care. This case highlights the need for a broader diagnostic approach, including comprehensive genetic testing and clinical correlation, especially for patients presenting with non-classical CF features. It contributes to the growing understanding that CF is a spectrum disorder with varied clinical and biochemical presentations, emphasizing the importance of individualized diagnosis and treatment strategies to optimize patient outcomes.